But it still can take months to produce a personalized vaccine, giving the cancer more time to spread.
The emerging cancer vaccines aim to target solid tumors without the side effects of chemotherapy, building on the success of COVID-19 vaccines.
Using genetic sequencing, personalized cancer vaccines train the immune system to identify and fight tumor-specific mutations.
Broad-based treatments provide a quicker path to treatment compared to personalized vaccines, according to CEO Mai-Britt Zocca.
[
add
]
[
|
|
...
]